Winton Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Winton Group's JAZZ Position: Q2 2026 in Review
Winton Group opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1,600 shares worth $386K. The stake represents 0.01% of the portfolio and ranks #794 among its holdings. This is a return to the name: Winton Group previously reported a position in JAZZ as recently as Q3 2024.
Winton Group first reported a position in JAZZ in Q2 2017 and has held it in 16 quarters since. The position peaked at $8.41M in Q4 2019. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Winton Group held 1,600 shares of Jazz Pharmaceuticals worth $386K as of Q2 2026.
- Jazz Pharmaceuticals was a new Winton Group position in Q2 2026.
- Jazz Pharmaceuticals made up 0.01% of Winton Group's portfolio in Q2 2026, its #794 holding.
- Winton Group first reported a position in Jazz Pharmaceuticals in Q2 2017 and has held it in 16 quarters since.
- Winton Group's Jazz Pharmaceuticals position peaked at $8.41M in Q4 2019.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.